AMPH
Price
$50.83
Change
-$0.00 (-0.00%)
Updated
Oct 16 closing price
18 days until earnings call
ORGO
Price
$3.25
Change
-$0.00 (-0.00%)
Updated
Oct 16 closing price
20 days until earnings call
Ad is loading...

AMPH vs ORGO

Header iconAMPH vs ORGO Comparison
Open Charts AMPH vs ORGOBanner chart's image
Amphastar Pharmaceuticals
Price$50.83
Change-$0.00 (-0.00%)
Volume$283.42K
CapitalizationN/A
Organogenesis Holdings
Price$3.25
Change-$0.00 (-0.00%)
Volume$304.48K
CapitalizationN/A
View a ticker or compare two or three
AMPH vs ORGO Comparison Chart
Loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
AMPH vs. ORGO commentary
Oct 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMPH is a Buy and ORGO is a Buy.

COMPARISON
Comparison
Oct 18, 2024
Stock price -- (AMPH: $50.83 vs. ORGO: $3.25)
Brand notoriety: AMPH and ORGO are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMPH: 80% vs. ORGO: 56%
Market capitalization -- AMPH: $2.11B vs. ORGO: $374.78M
AMPH [@Pharmaceuticals: Other] is valued at $2.11B. ORGO’s [@Pharmaceuticals: Other] market capitalization is $374.78M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.36B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMPH’s FA Score shows that 1 FA rating(s) are green whileORGO’s FA Score has 1 green FA rating(s).

  • AMPH’s FA Score: 1 green, 4 red.
  • ORGO’s FA Score: 1 green, 4 red.
According to our system of comparison, AMPH is a better buy in the long-term than ORGO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMPH’s TA Score shows that 5 TA indicator(s) are bullish while ORGO’s TA Score has 6 bullish TA indicator(s).

  • AMPH’s TA Score: 5 bullish, 4 bearish.
  • ORGO’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, ORGO is a better buy in the short-term than AMPH.

Price Growth

AMPH (@Pharmaceuticals: Other) experienced а +9.74% price change this week, while ORGO (@Pharmaceuticals: Other) price change was +7.62% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +8.21%. For the same industry, the average monthly price growth was +10.22%, and the average quarterly price growth was -2.43%.

Reported Earning Dates

AMPH is expected to report earnings on Mar 12, 2025.

ORGO is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+8.21% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMPH($2.11B) has a higher market cap than ORGO($375M). ORGO has higher P/E ratio than AMPH: ORGO (70.25) vs AMPH (16.69). AMPH YTD gains are higher at: -17.817 vs. ORGO (-20.538). AMPH has higher annual earnings (EBITDA): 240M vs. ORGO (36M). AMPH has more cash in the bank: 257M vs. ORGO (104M). ORGO has less debt than AMPH: ORGO (119M) vs AMPH (624M). AMPH has higher revenues than ORGO: AMPH (644M) vs ORGO (433M).
AMPHORGOAMPH / ORGO
Capitalization2.11B375M563%
EBITDA240M36M667%
Gain YTD-17.817-20.53887%
P/E Ratio16.6970.2524%
Revenue644M433M149%
Total Cash257M104M247%
Total Debt624M119M524%
FUNDAMENTALS RATINGS
AMPH vs ORGO: Fundamental Ratings
AMPH
ORGO
OUTLOOK RATING
1..100
1321
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
78
Overvalued
PROFIT vs RISK RATING
1..100
30100
SMR RATING
1..100
3892
PRICE GROWTH RATING
1..100
4443
P/E GROWTH RATING
1..100
9016
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AMPH's Valuation (72) in the Pharmaceuticals Other industry is in the same range as ORGO (78) in the Financial Conglomerates industry. This means that AMPH’s stock grew similarly to ORGO’s over the last 12 months.

AMPH's Profit vs Risk Rating (30) in the Pharmaceuticals Other industry is significantly better than the same rating for ORGO (100) in the Financial Conglomerates industry. This means that AMPH’s stock grew significantly faster than ORGO’s over the last 12 months.

AMPH's SMR Rating (38) in the Pharmaceuticals Other industry is somewhat better than the same rating for ORGO (92) in the Financial Conglomerates industry. This means that AMPH’s stock grew somewhat faster than ORGO’s over the last 12 months.

ORGO's Price Growth Rating (43) in the Financial Conglomerates industry is in the same range as AMPH (44) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew similarly to AMPH’s over the last 12 months.

ORGO's P/E Growth Rating (16) in the Financial Conglomerates industry is significantly better than the same rating for AMPH (90) in the Pharmaceuticals Other industry. This means that ORGO’s stock grew significantly faster than AMPH’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMPHORGO
RSI
ODDS (%)
Bearish Trend 2 days ago
72%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
59%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
74%
MACD
ODDS (%)
Bullish Trend 2 days ago
66%
Bullish Trend 2 days ago
78%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
77%
Declines
ODDS (%)
Bearish Trend 15 days ago
66%
Bearish Trend 17 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
74%
Bearish Trend 2 days ago
83%
Aroon
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
88%
View a ticker or compare two or three
Ad is loading...
AMPH
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
ORGO
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME21.660.39
+1.83%
GameStop Corp
BTC.X67612.720000571.609400
+0.85%
Bitcoin cryptocurrency
TSLA221.331.76
+0.80%
Tesla
SPY582.302.52
+0.43%
SPDR® S&P 500® ETF Trust
AAPL231.78-2.07
-0.89%
Apple

AMPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMPH has been loosely correlated with SUPN. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if AMPH jumps, then SUPN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMPH
1D Price
Change %
AMPH100%
+3.08%
SUPN - AMPH
35%
Loosely correlated
+1.37%
AMRX - AMPH
30%
Poorly correlated
-1.25%
VTRS - AMPH
27%
Poorly correlated
-0.17%
DVAX - AMPH
26%
Poorly correlated
+2.51%
ORGO - AMPH
26%
Poorly correlated
+1.56%
More

ORGO and

Correlation & Price change

A.I.dvisor indicates that over the last year, ORGO has been loosely correlated with AMRX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ORGO jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGO
1D Price
Change %
ORGO100%
+1.56%
AMRX - ORGO
39%
Loosely correlated
-1.25%
ESPR - ORGO
32%
Poorly correlated
-0.47%
ANIP - ORGO
30%
Poorly correlated
+1.81%
ACET - ORGO
29%
Poorly correlated
+6.43%
AMPH - ORGO
27%
Poorly correlated
+3.08%
More